PATH250117P15000
- 1.73
- -0.49-22.07%
UiPath Newsroom
UiPath Price Target Cut to $15.00/Share From $16.00 by Barclays
UiPath Is Maintained at Equal-Weight by Barclays
UiPath Analyst Ratings
Barclays Maintains UiPath(PATH.US) With Hold Rating, Cuts Target Price to $15
Barclays Sticks to Their Hold Rating for UiPath (PATH)
Needham Maintains UiPath(PATH.US) With Hold Rating
UiPath Maintains Hold Rating Amid Mixed Demand Signals and Regional Disparities
UiPath Analyst Ratings
UiPath Initiated at Sell by UBS
UiPath Analyst Ratings
UBS Initiates UiPath(PATH.US) With Sell Rating, Announces Target Price $14
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $15 to $18
UiPath Price Target Raised to $16.00/Share From $15.00 by Barclays
UiPath Price Target Raised to $16.00/Share From $15.00 by Morgan Stanley
UiPath Price Target Raised to $16.00/Share From $15.00 by BMO Capital
UiPath Price Target Maintained With a $16.00/Share by RBC Capital
UiPath Is Maintained at Overweight by JP Morgan
JP Morgan Maintains Overweight on UiPath, Raises Price Target to $18
A Quick Look at Today's Ratings for UiPath(PATH.US), With a Forecast Between $16 to $19
UiPath's Growth Potential and Favorable Valuation Supports Buy Rating